(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






S&P 500 Boosts Lululemon; Pfizer Lowers Profits, Revenue Outlook

  • October 13th, 2023
  • 435 views

Lululemon Athletica Inc. (Nasdaq: LULU), a notable athletic apparel company, will replace Activision Blizzard Inc. (Nasdaq: ATVI) in the S&P 500 index, effective at the opening of trading on Wednesday, October 18.

The S&P 500 is widely recognized as a benchmark for the U.S. stock market, comprising 500 leading companies with significant market capitalization. As a constituent of the S&P 500, Lululemon Athletica will represent its industry among other major sectors.

$LULU was trading at $395.88 in after-hours, up $18.18 (4.81%) following the announcement.

In other news, Pfizer Inc. (NYSE: PFE) is revising its guidance. Solely from its COVID products, the pharmaceutical giant now expects its full-year 2023 revenues to fall between $58.0 billion and $61.0 billion, down from the prior guidance range of $67.0 billion to $70.0 billion. As a result, Pfizer now expects adjusted diluted earnings per share (EPS) to range from $1.45 to $1.65, compared to the initial EPS range of $3.25 to $3.45 for the period

In after-hours, $PFE was trading at $31.03, down $1.08 (-3.36%)

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13